Nifty
Sensex
:
:
11706.75
39050.21
34.60 (0.30%)
89.42 (0.23%)

Pharmaceuticals & Drugs

Rating :
73/99  (View)

BSE: 524742 | NSE: CAPLIPOINT

408.80
-1.55 (-0.38%)
18-Jun-2019 | 10:29AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  408.00
  •  411.35
  •  402.25
  •  410.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4878
  •  19.94
  •  537.90
  •  296.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,124.05
  • 17.69
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,045.30
  • 0.48%
  • 5.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.04%
  • 1.82%
  • 17.44%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 11.68%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 31.26

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.92

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 46.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.68
  • 32.10
  • 31.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.46
  • 13.82
  • 13.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.87
  • 21.72
  • 21.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
187.34
143.41
30.63%
159.03
141.61
12.30%
155.86
131.31
18.70%
146.46
123.51
18.58%
Expenses
122.58
94.69
29.45%
101.27
90.82
11.51%
100.08
81.95
22.12%
93.43
77.61
20.38%
EBITDA
64.76
48.72
32.92%
57.76
50.79
13.72%
55.78
49.36
13.01%
53.03
45.90
15.53%
EBIDTM
34.57%
33.97%
36.32%
35.87%
35.79%
37.59%
36.21%
37.16%
Other Income
2.67
2.90
-7.93%
7.74
2.33
232.19%
7.01
3.58
95.81%
1.61
3.86
-58.29%
Interest
0.01
0.01
0.00%
0.02
0.02
0.00%
0.02
0.02
0.00%
0.01
0.02
-50.00%
Depreciation
6.72
6.18
8.74%
5.67
4.53
25.17%
5.58
4.45
25.39%
5.45
3.85
41.56%
PBT
60.69
45.43
33.59%
59.81
48.58
23.12%
57.20
48.47
18.01%
49.17
45.90
7.12%
Tax
10.84
10.13
7.01%
14.00
11.10
26.13%
13.70
12.94
5.87%
11.78
9.58
22.96%
PAT
49.86
35.29
41.29%
45.81
37.48
22.23%
43.50
35.54
22.40%
37.39
36.33
2.92%
PATM
26.61%
24.61%
28.80%
26.47%
27.91%
27.06%
25.53%
29.41%
EPS
6.59
4.68
40.81%
6.06
4.97
21.93%
5.75
4.71
22.08%
4.95
4.81
2.91%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Net Sales
648.69
539.84
401.65
238.72
251.77
173.09
127.03
107.22
80.78
Net Sales Growth
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
32.73%
 
Cost Of Goods Sold
288.78
238.18
184.93
121.16
135.62
102.58
84.45
77.36
60.88
Gross Profit
359.91
301.66
216.72
117.56
116.15
70.50
42.58
29.85
19.89
GP Margin
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
24.62%
Total Expenditure
417.36
344.52
276.84
174.51
192.06
136.90
104.68
96.06
71.58
Power & Fuel Cost
-
10.98
9.91
7.56
8.61
3.07
1.12
0.84
0.68
% Of Sales
-
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
0.84%
Employee Cost
-
37.61
29.71
17.92
18.24
12.63
7.69
6.28
4.14
% Of Sales
-
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
5.13%
Manufacturing Exp.
-
37.11
28.56
14.33
16.04
7.42
3.07
1.63
1.54
% Of Sales
-
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
1.91%
General & Admin Exp.
-
14.54
13.78
8.15
7.97
6.54
4.67
3.58
3.00
% Of Sales
-
2.69%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
3.71%
Selling & Distn. Exp.
-
6.01
9.41
2.29
2.85
1.46
1.02
0.91
0.67
% Of Sales
-
1.11%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
0.83%
Miscellaneous Exp.
-
0.10
0.55
3.10
2.72
3.19
2.66
5.44
0.66
% Of Sales
-
0.02%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
0.82%
EBITDA
231.33
195.32
124.81
64.21
59.71
36.19
22.35
11.16
9.20
EBITDA Margin
35.66%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
11.39%
Other Income
19.03
12.67
9.96
3.66
3.03
3.72
2.10
2.51
2.55
Interest
0.06
0.61
0.52
0.34
0.97
0.68
0.77
1.26
1.20
Depreciation
23.42
19.00
13.30
7.48
8.38
3.54
1.54
1.24
2.32
PBT
226.87
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Tax
50.32
43.74
25.44
14.28
12.26
9.76
8.12
3.14
1.91
Tax Rate
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
23.24%
PAT
176.56
144.78
95.61
45.77
41.04
25.85
13.98
8.01
6.28
PAT before Minority Interest
176.57
144.63
95.50
45.77
41.13
25.93
14.02
8.03
6.31
Minority Interest
0.01
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
-0.03
PAT Margin
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
7.77%
PAT Growth
22.07%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
27.55%
 
Unadjusted EPS
23.35
19.26
12.65
30.28
27.16
17.11
9.25
5.30
4.16

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Shareholder's Funds
363.83
224.76
128.14
93.19
61.74
43.14
33.58
29.08
Share Capital
15.12
15.12
15.11
15.11
15.11
15.11
15.11
15.11
Total Reserves
345.42
209.56
111.40
78.08
46.63
28.03
18.47
13.97
Non-Current Liabilities
27.86
19.90
13.69
10.39
10.42
8.66
4.29
1.82
Secured Loans
0.32
0.48
0.73
0.88
2.07
3.48
1.55
0.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.40
1.63
0.82
0.81
0.38
0.27
0.20
Current Liabilities
108.67
113.36
125.04
124.97
107.58
83.01
69.20
40.44
Trade Payables
94.23
78.60
55.71
41.56
31.50
25.64
21.26
17.06
Other Current Liabilities
12.66
33.09
60.39
72.11
66.42
50.85
38.33
10.71
Short Term Borrowings
0.00
0.00
0.00
0.05
0.05
0.05
5.20
9.46
Short Term Provisions
1.78
1.67
8.94
11.25
9.60
6.47
4.41
3.22
Total Liabilities
500.45
358.38
267.14
228.82
179.92
134.90
107.12
71.37
Net Block
169.48
151.83
144.23
113.13
102.24
32.71
27.54
24.95
Gross Block
231.79
195.15
180.76
142.71
123.06
50.06
43.36
39.53
Accumulated Depreciation
62.31
43.31
36.53
29.58
20.82
17.36
15.82
14.58
Non Current Assets
237.46
179.16
148.61
146.95
131.30
96.21
53.41
30.12
Capital Work in Progress
15.29
3.42
0.23
30.63
24.54
48.98
12.79
0.17
Non Current Investment
41.45
13.24
0.44
0.45
0.44
1.19
1.14
1.15
Long Term Loans & Adv.
11.23
10.67
3.71
2.75
3.67
10.83
11.94
3.85
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
263.00
179.22
118.53
81.87
48.61
38.70
53.71
41.25
Current Investments
5.22
4.20
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
28.46
22.29
18.81
13.66
9.79
10.42
6.38
5.50
Sundry Debtors
125.88
33.02
7.95
5.66
0.09
0.86
7.28
8.33
Cash & Bank
79.28
93.07
68.10
45.37
26.82
16.84
31.80
21.62
Other Current Assets
24.16
7.32
11.09
6.10
11.90
10.57
8.25
5.80
Short Term Loans & Adv.
17.28
19.31
12.58
11.08
8.16
5.61
4.50
3.44
Net Current Assets
154.33
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
0.81
Total Assets
500.46
358.38
267.14
228.82
179.91
134.91
107.12
71.37

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Cash From Operating Activity
66.48
67.61
42.40
49.88
59.83
31.95
27.92
14.25
PBT
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Adjustment
14.83
8.61
3.87
6.21
2.14
-0.21
-0.25
2.06
Changes in Working Capital
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
4.49
Cash after chg. in Working capital
102.83
91.16
58.78
61.56
67.15
37.75
29.81
14.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
-0.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
-6.90
Net Fixed Assets
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
-0.37
Net Cash Inflow / Outflow
-14.14
24.76
22.73
18.55
9.99
-14.97
10.18
6.98
Opening Cash & Equivalents
91.31
66.55
45.37
26.82
16.84
31.80
21.62
14.64
Closing Cash & Equivalent
77.17
91.31
68.10
45.37
26.82
16.84
31.80
21.62

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Book Value (Rs.)
47.69
29.73
16.25
11.84
7.68
5.22
3.95
3.36
ROA
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
8.84%
ROE
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
24.90%
ROCE
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
26.87%
Fixed Asset Turnover
2.53
2.14
1.48
1.89
2.00
2.73
2.61
2.04
Receivable days
53.72
18.62
10.40
4.17
1.00
11.66
26.30
37.63
Inventory Days
17.16
18.68
24.83
17.00
21.31
24.06
20.01
24.84
Payable days
89.66
88.17
103.48
69.75
79.69
85.60
79.07
88.42
Cash Conversion Cycle
-18.78
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
-25.95
Total Debt/Equity
0.00
0.00
0.02
0.02
0.06
0.12
0.23
0.38
Interest Cover
309.72
235.08
179.35
56.11
53.29
29.73
9.88
7.84

News Update


  • USFDA completes inspection at Caplin Point Laboratories’ Steriles Injectable site
    17th Jun 2019, 11:41 AM

    At the end of this scheduled GMP inspection, there were only two observations

    Read More
  • Caplin Point gets Colombia's INVIMA approval for sterile injectables
    13th May 2019, 11:11 AM

    The site inspection of Unit-1 was completed on May 10

    Read More
  • Caplin Point Laboratories’ arm enters into license & supply agreement with Baxter
    8th Apr 2019, 11:18 AM

    An agreement with Baxter Healthcare Corporation is for five generic injectable ANDAs

    Read More
  • Caplin Point Laboratories’ arm gets USFDA’s nod for Glycopyrrolate injection
    22nd Mar 2019, 14:12 PM

    Glycopyrrolate had US sales data of approximately $110.12 Million for the 12 month period ending December 2018

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.